Stelo Launch And Dispelling GLP-1s: Dexcom’s Sayer Speaks

 
• By Barnaby Pickering

Dexcom’s CEO, Kevin Sayer, ahead of this year’s Advanced Technologies & Treatments for Diabetes conference, shared an update on the company’s recent news, future strategy and where he feels the market is headed.  

• Source: Shutterstock

More from Leadership

More from In Vivo